PE-22-28 is a synthetic heptapeptide derived from Pigment Epithelium-Derived Factor (PEDF), one of the most potent endogenous neuroprotective proteins identified. By isolating the neurotrophic signaling domain of PEDF into a small, stable peptide format, PE-22-28 provides researchers with a tool to study PEDF-mediated neuroprotection without the complexity of the full 50 kDa protein. Research demonstrates neuroprotective, neurotrophic, and cognitive-enhancing effects in preclinical models.
PEDF: The Parent Protein
Pigment Epithelium-Derived Factor was first identified in 1989 by Joyce Tombran-Tink in conditioned media from human retinal pigment epithelial cells. PEDF is a 50 kDa secreted glycoprotein belonging to the serine protease inhibitor (serpin) superfamily, though it lacks protease inhibitory activity. Instead, PEDF is a multifunctional protein with potent neuroprotective, anti-angiogenic, anti-tumorigenic, and anti-inflammatory properties.
In the nervous system, PEDF protects retinal neurons, cortical neurons, hippocampal neurons, motor neurons, and cerebellar granule cells against a variety of insults including glutamate excitotoxicity, oxidative stress, ischemia, and trophic factor withdrawal. PEDF is one of the most abundant proteins in cerebrospinal fluid and vitreous humor, suggesting important physiological roles in CNS homeostasis.
PE-22-28: The Neurotrophic Fragment
Structure-activity studies mapped PEDF’s neurotrophic function to a short N-terminal region. The heptapeptide corresponding to amino acids 22-28 was found to retain the neuroprotective and neurotrophic signaling capacity of the full protein. This fragment activates the PEDF receptor (PEDF-R, also known as PNPLA2/ATGL), a membrane-associated phospholipase that mediates PEDF’s neuroprotective signaling.
PE-22-28 binding to PEDF-R triggers a signaling cascade involving NF-kB nuclear translocation (specifically the p65/RelA survival-promoting form), which upregulates anti-apoptotic proteins (Bcl-2, Bcl-xL), BDNF expression, and antioxidant enzyme transcription. This pathway protects neurons against apoptosis and promotes synaptic maintenance and neuroplasticity.
Neuroprotection Research
In retinal ganglion cell models, PE-22-28 protected against glutamate excitotoxicity with efficacy comparable to full-length PEDF. The peptide reduced caspase-3 activation, maintained mitochondrial membrane potential, and preserved neurite integrity under excitotoxic conditions. In cortical neuron cultures exposed to oxidative stress (hydrogen peroxide), PE-22-28 reduced cell death by 40-60% at nanomolar concentrations.
In vivo studies in retinal ischemia-reperfusion models showed that PE-22-28 administration preserved retinal ganglion cell density and function (measured by electroretinography) following ischemic injury. These findings are relevant to glaucoma and diabetic retinopathy research where PEDF signaling is compromised.
Cognitive Enhancement
PE-22-28’s BDNF-upregulating effects have implications for cognitive function. In rodent models, the peptide improved hippocampal-dependent memory tasks. The mechanism involves enhanced hippocampal LTP through BDNF/TrkB signaling and improved synaptic marker expression (synaptophysin, PSD-95). These findings parallel the cognitive effects of Semax and Dihexa, though through a distinct receptor system.
Advantages as a Research Tool
PE-22-28 offers several advantages over full-length PEDF for research. Its small size (7 amino acids) enables chemical synthesis with high purity and low cost, intranasal and systemic administration with good bioavailability, straightforward structure-activity relationship studies, and compatibility with various delivery formulations. Full-length PEDF requires recombinant protein production with associated costs and variability.
Frequently Asked Questions
What is PE-22-28?
A synthetic heptapeptide from PEDF protein (amino acids 22-28) that retains neuroprotective and neurotrophic signaling properties in a small, stable format.
How does PE-22-28 provide neuroprotection?
It activates the PEDF receptor, triggering NF-kB survival signaling, BDNF upregulation, and anti-apoptotic protein expression. It also has antioxidant and anti-excitotoxic properties.
What is PEDF?
A 50 kDa neuroprotective glycoprotein, one of the most potent natural neuroprotective factors known, with roles in retinal, CNS, and peripheral nervous system protection.